The duration of endocrine therapy and breast cancer patients’ survival: A nationwide population-based cohort study

As research progressed, the recommended duration of endocrine therapy for breast cancer patients has been extended from 5 to 10 years. This study aimed to investigate how the duration of endocrine medication and therapy affect survival rate in the real world. By using the National Health Insurance R...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chuan-Hsun, Huang, Chun-Wen, Huang, Chien-Ming, Ou, Tzu-Chi, Chen, Chu-Chieh, Lu, You-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824710/
https://www.ncbi.nlm.nih.gov/pubmed/31651908
http://dx.doi.org/10.1097/MD.0000000000017746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824710/
https://www.ncbi.nlm.nih.gov/pubmed/31651908
http://dx.doi.org/10.1097/MD.0000000000017746

Ejemplares similares